alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 1977 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 1977

    To extend and modify the temporary suspension of duty on 9, 10-
                            Anthracenedione.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 28, 2009

 Ms. Cantwell introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To extend and modify the temporary suspension of duty on 9, 10-
                            Anthracenedione.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 9, 10-ANTHRACENEDIONE.

    (a) In General.--Heading 9902.24.05 of the Harmonized Tariff 
Schedule of the United States (relating to 9, 10-Anthracenedione) is 
amended--
            (1) by striking the article description and inserting the 
        following: ``Mixtures of 2-tert-amyl 9, 10-anthraquinone (CAS 
        No. 32588-54-8) and 2-iso-amyl-9, 10-anthraquinone (CAS No. 
        68892-28-4) (provided for in subheading 2914.69.60) or in 
        organic solution (provided for in subheading 3824.90.28)''; and
            (2) by striking ``12/31/2009'' and inserting ``12/31/
        2011''.
    (b) Effective Date.--The amendments made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<PAGE>   1
                                                                   EXHIBIT 23.1a



               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-32725) pertaining to the 1994 Stock Plan and the 1996 Employee Stock
Purchase Plan of UroQuest Medical Corporation of our report dated February 12,
1999, with respect to the consolidated financial statements of UroQuest Medical
Corporation included in the Annual Report (Form-10-K) for the year ended
December 31, 1998.

                                                   /s/ ERNST & YOUNG LLP


   Palo Alto, California
   March 30, 1999
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLAR

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                           JUN-3-2000
<PERIOD-START>                              JUN-1-1999
<PERIOD-END>                                JUN-3-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          72,060
<SECURITIES>                                    28,236
<RECEIVABLES>                                  131,651
<ALLOWANCES>                                   (2,549)
<INVENTORY>                                     81,192
<CURRENT-ASSETS>                               313,891
<PP&E>                                         131,132
<DEPRECIATION>                                (43,219)
<TOTAL-ASSETS>                                 435,080
<CURRENT-LIABILITIES>                           75,695
<BONDS>                                        115,162
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                     236,969
<TOTAL-LIABILITY-AND-EQUITY>                   435,080
<SALES>                                        274,048
<TOTAL-REVENUES>                               274,048
<CGS>                                          184,527
<TOTAL-COSTS>                                  184,527
<OTHER-EXPENSES>                               106,070
<LOSS-PROVISION>                                    82
<INTEREST-EXPENSE>                             (8,008)
<INCOME-PRETAX>                               (10,900)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (14,178)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (14,178)
<EPS-BASIC>                                     (0.48)
<EPS-DILUTED>                                   (0.48)


</TABLE>
### SERVED: April14,2014 U.S. DEPARTMENT OF TRANSPORTATION OFFICE OF HEARINGS

WASHINGTON, DC

IN THE MATTER OF 

### RADIO HOLLAND USA, INC. FAA DOCKET No. [TO BE ASSIGNED] (Civil Penalty Action) FDMS No. F AA-2013-0286 

### ORDER OF DISMISSAL OnMay 16,2013,the Federal.Aviation Administration ("Complainant") filed a Complaint. Radio HollandUSA., Inc. ("Respondent") had filed a Request for Hearing on May 17, 2013. · OnApri19, 2014, Respondent withdrew its Request for Hearing, citing settlement. 14 C.F

### .R. § 13.215 states: "At any time before or during a hearing, an agency attorney may withdraw a complaint orparty may withdraw a request for a hearing without the consent ofthe administrative lawjudge. Ifan agency attorney withdraws the complaint or a party withdraws the request for a hearing and the answer, the administrative lawjudge shall dismiss the proceedings underthis subpart withprejudice."

### WHEREFORE, the within filed Withdrawal ofRequest for Hearing having beenread and considered, itis ORDERED as follows: 1. 

### Respondent's Withdrawal ofRequest for Hearing be and is hereby granted; and 2. This proceeding be and is hereby dismissed with prejudice.

Richard C. Goodwin U.S. Administrative LawJudge Attachment

- Se:i:vice List

2

### FDMS No. FAA-2013-0286 (Civil Penalty Action) SERVICE LIST-BY U.S. MAIL & FAX ORIGINAL & ONE COPY 

### Federal Aviation Administration 800 Independence Avenue, S.W. Washington, DC 20591 Attention: Hearing Docket Clerk, AGC-430 WilburWright Building-Suite 2W1000 1 ONE COPY 

### Jeanine Gotimer, Complainant's Counsel 

### Attorney, Office ofthe Regional Counsel Eastern Region Federal Aviation Administration 1 Aviation Plaza Jamaica, NY 11434 TEL: 718-553-3272 FAJ(: 718-995-5699 Anacarolina Estaba, Respondent's Counsel 

### Gardere Wynne Sewell, LLP 1000 Louisiana, Suite 3400 Houston, TX77002-5011 TEL: 713-276-5398 FAX: 713-276-6398 The Honorable Richard C. Goodwin,AdministrativeLawJudge 

### Office ofHearings, M-20 U.S. Department ofTransportation 1200NewJersey Avenue, S.E. (Ell-310) Washington, DC 20590 TEL: 202-366-5121 StaffAssistant FAX: 202-366-7536

1 Service was by U.S. Mail. For service in person orby expedited courier, use the following address: Federal Aviation Administration, 600 IndependenceAvenue, S.W., Wilbur Wright Building-Suite 2W1000, Washington, DC 20591, Attention: Hearing Docket Clerk, AGC-430. 

### 3
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 1807 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 1807

  To extend the temporary suspension of duty on hexythiazox technical.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 20, 2009

    Mr. Kyl introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To extend the temporary suspension of duty on hexythiazox technical.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. HEXYTHIAZOX TECHNICAL.

    (a) In General.--Heading 9902.12.08 of the Harmonized Tariff 
Schedule of the United States (relating to hexythiazox technical) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Chelsea Therapeutics International, Ltd. (the
Company) for the period ended September 30, 2006 as filed with the Securities and Exchange Commission on or about the date hereof (the Report), I, Simon Pedder, President and Chief Executive Officer, hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods
presented in the Report.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Simon PedderSimon PedderPresident and Chief Executive OfficerNovember 13, 2006
#### NORTHEAST SAVINGS, F.A. *v.*JACK S. SCHERBAN ET AL.

*M. Dean Montgomery,*in support of the petition.

*Elaine M. Scanlon,*in opposition.

Decided March 5, 1998

The defendants Jack S. Scherban and Andrea L. Scherban’s petition for certification for appeal from the Appellate Court, 47 Conn. App. 225 (AC 16705), is denied.
Exhibit 10.28


 


Credit Contract


 


(Contract No. :  [2016-0170])


 


Borrower: Chongqing Penglin
Food Co. Ltd.


Address: 128 Xinyuan Road, Zhenxi Town,
Beiling District, Chongqing City


Legal representative: Zeshu Dai


 


Lender: Chongqing Dadukou Village &
Township Bank


 


		I.	Loan



 


	 	1.	Type: Liquid capital loan


 


	 	2.	Purpose: working capital


 


	 	3.	Currency: RMB.


 


	 	4.	Amount: ¥6,370,000


 


	 	5.	Term: long term


 


	 	6.	Period: 24 months, from September 21, 2018 to September 20, 2020


 


		II.	Loan interest rate, interest calculation and interest
settlement



 


	 	1.	Loan interest rate: Fixed rate, Annual interest rate is 12%.


 


	 	2.	Penalty interest rate:


 


If Borrower does not repay the
loan on time, penalty interest rate shall be 150% of the loan interest under this contract.


 


If the loan is used in violation
of the purpose of this contract, the penalty interest shall be 200% of the loan interest under this contract.


 


		3.	Loan interest shall be settled monthly on the 20th day
of each month.



 


	 	III.	Guarantee:


 


	 	1.	The guarantee type for performance of this contract is guarantee and pledge.


 


	Name of Guarantor and Pledge	 	Contract No.	 	Guarantee Type
	
        Chongqing Penglin Food Co. Ltd.

        Chongqing Guang’an Yongpeng Food
        Co. Ltd.

        Chongqing Pengmei Supermarket Co. Ltd.

        Chongqing Mingwen food Co. Ltd.
	 	 	 	
        Guarantee

        Guarantee

        Guarantee

        Guarantee

	Chongqing Fu Yong Sheng Food Supermarket Co., Ltd.	 	 	 	Guarantee
	Mingwen Wang	 	 	 	Guarantee
	Zeshu Dai	 	 	 	Guarantee
	Penglin Wang	 	 	 	Guarantee
	Yong Wang	 	 	 	Guarantee


 


	 	IV.	Repayment of Loan Principal


 


	 	1.	Interest shall be settled and paid monthly on the 20th day of each month.
	 	2.	Principal shall be repaid in the amount of $1,000,000 every 6 moths with the remaining payable on maturity date.


 






     


     


    

 


	V.	Miscellaneous:


 


	 	1.	If Party A doesn’t perform or doesn’t fully perform its contractual obligations, it is willing to accept enforcement based on the law.


 


	 	2.	Any agreement on the amount of credit doesn’t mean lender must give the amount to the borrower. The lender has the right to adjust the amount and the borrower irrevocably agrees and confirms.


 


	 	3.	This contract comes into effect upon execution by legal representative of each party and stamped by both parties.


 


Lender: /s/ Chongqing Dadukou
Village & Township Bank


 


Borrower: /s/ Chongqing
Penglin Food Co. Ltd.


 


Execution date: September 20,
2018
II 

111TH CONGRESS 

1ST SESSION S. 1967 

To extend the suspension of duty on formulations of thiamethoxam, 

difenoconazole, fludioxonil, and mefenoxam. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 28, 2009 

Mr. CRAPO introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the suspension of duty on formulations of 

thiamethoxam, difenoconazole, fludioxonil, and mefenoxam. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. FORMULATIONS OF THIAMETHOXAM, DIFENO4 CONAZOLE, FLUDIOXONIL, AND MEFENOXAM. 

5 (a) IN GENERAL.—Heading 9902.13.31 of the Har6 monized Tariff Schedule of the United States (relating to 

7 formulations of Thiamethoxam, Difenoconazole, Fludiox8 onil, and Mefenoxam) is amended by striking ‘‘12/31/ 

9 2009’’ and inserting ‘‘12/31/2011’’. 


wwoods2 on DSK1DXX6B1PROD with BILLS
2 

•S 1967 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ 


wwoods2 on DSK1DXX6B1PROD with BILLS
CERTIFICATION PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

(18 U.S.C. SECTION 1350)

 

In connection with the report of Razor Resources Inc. (the "Company"), on Form 10-QSB/A for the quarter endingJanuary 31, 2008, as filed with the Securities and Exchange Commission (the "Report"), I,Jordan Welsh, Chief Executive Officer of the Company, certify, pursuant to Sect 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Sect 1350), that to my knowledge: 

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. 

 

/s/ Jordan Welsh                                    

Jordan Welsh, 

Chief Executive Officer

Dated: April 10, 2008
The following Public Notice was published in the following newspapers: 

Indianapolis Star —October 15, 2012 

Fort Wayne Journal Gazette — October 16, 2012 

Evansville Courier —October 18, 2012 

Post Tribune (NW Indiana) — October 18, 2012 

In the notice, please note that comments will be accepted until November 26, 2012. 
PUBLIC NOTICE: AUTHORIZATION OF INDIANA'S STATE HAZARDOUS 

WASTE MANAGEMENT PROGRAM 

What is United States Environmental Protection Agency (U.S. EPA) doing through 

this notice? 

In accordance with Title 40 of the United States Code of Federal Regulations, Part 

271.21, the U.S. EPA Regional Administrator is giving notice of their decision, subject to 

public review and comment, that the State of Indiana's revised hazardous waste 

management program satisfies all of the requirements for authorization under the 

Resource Conservation and Recovery Act (RCRA), as amended by the Hazardous and 

Solid Waste Amendments of 1984 (HSWA). 

What changes to the State of Indiana Authorization are included in this revision? 

The State program revision includes, but is not limited to, the following provisions: 

Burning of Hazardous Waste in Boilers and Industrial Furnaces (BIF) Including 

BIF/MACT; Recycled Zinc Fertilizers; Modification of the Manifest; Standardized 

RCRA Permit; Academic Labs Rule. 

Why are the revisions necessary? 

These State program revisions are necessary to maintain equivalency of State and Federal 

programs due to changes in U.S. EPA's regulations. 

Where can the public review copies of the Indiana application? 

Copies of Indiana's revised program application are available from 9:00 am to 4:00 p.m. 

at the following addresses for inspection and copying: 

Online at www.regulations.gov, docket EPA-R05-RCRA-2012-0377. 

Indiana Department of Environmental Management, 100 North Senate, 

Indianapolis, Indiana; Contact Dan Watts (317) 234-5345. 

Mr. Gary Westefer (LR-8J), U.S. EPA Region 5, 77 West Jackson Blvd, 8 thFloor, 

Chicago, IL 60604; Phone: (312) 886-7450. 

Where can the public send comments to? And by when? 

Comments will be accepted on Indiana's revised hazardous waste program until 

November 26, 2012. Submit comments to: Mr. Gary Westefer (LR-8J), Indiana 

Regulatory Specialist, U.S. EPA Region 5, 77 West Jackson Blvd, Chicago, IL 60604. 

Or at www.regulations.gov , docket EPA-R05-RCRA-2012-0377. 

More About Indiana's Program 

Indiana has been operating the Hazardous Waste Program under the Resource 

Conservation and Recovery Act (RCRA) since January 31, 1986. The State of Indiana 

rules covering the RCRA Federal regulations are found at 329 IAC (Indiana 

Administrative Code) 3.1 and 329 IAC 13.
⁄‘×ŸÿÃ›—“ÃŒ—‘ÕÛfl“Ÿ‘¤ ̄–×‘—Ã ̃”—‹¤⁄‘×ŸÿÃ›—“ÃŒ—‘ÕÛÿ—”¤”—‹¤‘¤‹ÕÃflÃÀÕ×“‹×›flÃ×—“ÕÃfl’×“Ÿ–ÿ—Ã—Õfl“‹Œ¤›—Œ‹×“Ÿ×‹¤—–Œ¤–flŒ×“ŸÃ—⁄‘«⁄‘«×“Ÿ‹×Õflfi‘×“ŸŸ–ÕŸŒfl–ÿ×›fl‘ÀÕ¤Œ×“Ã¤Œ⁄fl›¤ ̄ŸÀ× ̃›—”–flÕÕ›fl‘×fiŒflÃ×—“ÕÃÔðfl“‹›Ÿ—ÓÛŸfifi×“‹×“ŸÃŒ—Àfi‘¤Õÿ——Ã×“Ÿ...flŒŒfl“Ã«×“⁄—Œ”flÃ×—“
UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA FILED 

NOV - 3 ?J'l 

Clerk U S D' t . 

David P. Phillips, ) 

", ' . . IS net & Bankruptc I"ourts fur the Distr,ct of COllJmda 

) 

Plaintift~ ) 

) 

v. ) Civil Action No. ...1 1. J.; l 

) 

U.S.A., ) 

) 

Defendant. ) 

MEMORANDUM OPINION 

This matter is before the Court on its review of plaintiff's pro se complaint and 

application to proceed in forma pauperis. The application will be granted and the complaint will 

be dismissed for lack of subject matter jurisdiction. See Fed. R. Civ. P. 12(h)(3) (requiring 

dismissal of an action "at any time" the Court determines that it lacks subject matter jurisdiction). 

Plaintiff sues the United States for allegedly "refus[ing] to show paperwork in accordance 

for [sic] investigation of terror." Compl. He also alleges that defendant neglected to investigate 

"the theft of art ... through torture." Jd. Plaintiff seeks $30 trillion in damages. 

A claim for monetary damages against the United States is cognizable under the Federal 

Tort Claims Act ("FTCA"), 28 U.S.C. §§ 2671 et seq. Such a claim is maintainable, however, 

only after the plaintiff has exhausted administrative remedies by "first present[ing] the claim to 

the appropriate Federal agency .... " 28 U.S.C. § 2675. This exhaustion requirement is 

jurisdictional. See Abdurrahman v. Engstrom, 168 Fed.Appx. 445, 445 (D.C. Cir. 2005) (per 

curiam) ("[T]he district court properly dismissed case [based on unexhausted FTC A claim] for 

lack of subject matter jurisdiction."); accord GAF Corp. v. United States, 818 F.2d 901, 917-20 

(D.C. Cir. 1987); Jackson v. United States, 730 F.2d 808,809 (D.C. Cir. 1984); Stokes v. US. 

Postal Service, 937 F. Supp. 11, 14 (D.D.C. 1996). 

.3 
The plaintiff has not indicated that he exhausted his administrative remedies under the 

FTC A. Furthermore, the allegations "constitute the sort of patently insubstantial claims" that 

deprive the Court of subject matter jurisdiction. Tooley v. Napolitano, 586 F.3d 1006. 1010 

(D.C. Cir. 2009); see Caldwell v. Kagan, 777 F. Supp.2d 177, 178 (D.D.C. 2011) CA district 

court lacks subject matter jurisdiction when the complaint 'is patently insubstantial, presenting 

no federal question suitable for decision.''') (quoting Tooley, 586 F.3d at 1009). Hence, the 

Court, finding it impossible for plaintitIto overcome the jurisdictional barrier, will dismiss this 

action with prejudice. A separate Order accompanies this Memorandum Opinion. 

Date: October f (J , 2011 

2
EXHIBIT 31.1

CERTIFICATION

                         SPECTRE TECHNOLOGY CORPORATION
              CERTIFICATION PURSUANT TO SARBANES-OXLEY SECTION 302


I, Gary Haukeland, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Raven Gold
Corporation;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
issuer as of, and for, the periods presented in this quarterly report;

4. The issuer's other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

a) Designed such disclosure controls and procedures or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the issuer including its consolidated
subsidiary, is made known to us by others within those entities, particularly
during the period in which this report is being prepared; and

b) Evaluated the effectiveness of the issuer's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the issuer's internal control over
financial reporting that occurred during the issuer's most recent fiscal quarter
(the issuer's fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the issuer's
internal control over financial reporting;

5. The issuer's other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the issuer's
auditors and the audit committee of the issuer's board of directors (or persons
performing the equivalent functions);

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the issuer's ability to record, process, summarize
and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the issuer's internal controls over
financial reporting.






Date: September 19, 2006                           By:  /s/Gary Haukeland
                                                        -----------------
                                                        Gary Haukeland
                                                        Chief Executive Officer